Effect of diltiazen and metoprolol on left atrial appendix functions in patients with nonvalvular chronic atrial fibrillation

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 1, 2007, Pages 37-41

  Karaca, Ilgm ^a,b   Coşkun, Naci ^a   Yavuzkir, Mustafa ^a   Iikay, Erdoǧan ^a   Daǧli, Necati ^a   Işik, Ahmet ^a   Balin, Mehmet ^a   Akbulut, Mehmet ^a   Arslan, Nadi ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Diltiazem; Left atrial appendage; Metoprolol

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; ANTIARRHYTHMIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; HEART ATRIUM FUNCTION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; BLOOD FLOW VELOCITY; CHRONIC DISEASE; DILTIAZEM; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METOPROLOL; MIDDLE AGED; THROMBOEMBOLISM; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34047201721     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lip GYH, DiMarco JP. Supraventricular arrhythmias. In Crawford MH, DiMarco JP editors: Cardiology. London: Mosby; 2001. p.4.10.1-18.
2. Kennel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 1982; 306: 1018-22.
3. Prystowsky EN, Benson DW Jr, Fuster V, Hart RG, Kay GN, Myerburg RJ, et al. Management of patients with atrial fibrillation. Circulation 1996; 93: 1262-77.
4. Olgin JE, Zipes DP. Specific arrhythmias. Diagnosis and Treatment. In: Braunwald E, Zipes DP, Libby P, editors. Heart Disease 6th edition. Philadelphia: W.B. Saunders Company; 2001. p. 815-89.
5. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-up Study. Am J Med 1995; 98: 476-84.
6. Fatkin D, Kelly RP, Feneley MD. Relations between left atrial appendage blood flow velocity, spontaneous echo contrast and thromboembolic risk in vivo. J.Am Coll Cardiol 1994; 23: 961-9.
7. Mugge A, Kuhn H, Nikutta P, Grote J, Lopez JA, Daniel WG. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994; 23: 599-607.
8. Man-Son-Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA 1999; 282: 737-43.
9. Brignole M, Menozzi C. Control of rapid heart rate in patients with atrial fibrillation: drug or ablation? Pacing Clin Electrophysiol 1996; 19: 348-56.
10. Atwood JE, Sullivan M, Forbes S, Myers J, Pewen W, Olson HG, et al. Effect of beta- adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol 1987; 10: 314-20.
11. Lundstöm T, Ryden L. Ventricular rate control and exercise performance in chronic atrial fibrillation:effects of diltiazem and verapamil. J Am Coll Cardiol 1990; 16: 86-90.
12. Segal JB, Mcnamara RL, Miller MR, Kim N, Goodman SN, Powe NR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000; 49: 47-59.
13. Waldo AL, Van Wagoner DR. Atrial fibrillation: In: Spooner PM, Rosen MR, editors. Foundations of Cardiac Arrhythmias. Basic Concepts and Clinical Approaches. New York; Marcel Dekker Inc: 2001; pp. 479-512.
14. Jahangir A, Munger TM, Packer DL, Crijns HJG. Atrial fibrillation. In: Podrid PJ, Kowey PR, editors. Cardiac Arrhythmia. Mechanism, Diagnosis Management. Philadelphia; Lippincott Williams & Wilkins: 2001. p. 457-99.
15. Gosselink AT, Crijns HJ, van den Berg MP, van den Broek SA, Hillege H, Landsman ML, et al. Functional capacity before and after cardioversion of atrial fibrillation: A controlled study Br Heart J 1994; 72: 161-6.
16. Atwood JE. The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am Heart J 1989; 118: 913-8.
17. Carlsson J, Neuzner J, Rosenberg YD. Therapy of atrial fibrillation: Rhythm control versus rate control. Pacing Clin Electrophysiol 2000; 23: 891-903.
18. Van Gelder I, Crijins HGM, Tieleman RG, Brügemann J, De Kamp J, Gosselinka TM, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996; 156: 2585-92.
19. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A metaanalysis of randomized control trials. Circulation 1990; 82: 1106-16.
20. Hohnloser SH, Kuck KH, Lilienthal J. PIAF Investigators. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000; 356: 1789-94.
21. Results from the STAF Pilot Phase (Strategies of Treatment of Atrial Fibrillation). J Am Coll Cardiol 2001; 38: 603.
22. Hagens VE, Vermeulen KM, TenVergert EM, Van Veldhuisen DJ, Bosker HA, Kamp O, et al. RACE study group. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation - results from the Rate Control versus Electrical cardioversion (RACE) study. Eur Heart J 2004; 25: 1542-9.
23. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma I, et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Eng J Med 2002; 347: 1834-40.
24. The Planning and Screening Committees of the AFFIRM Study for NHLBI AFFIRM Investigators. Atrial Fibrillation Follow up Investigation of Rhythm Management the AFFIRM Study design. Am J Cardiol 1997; 79: 1198-202.
25. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1826-33.
26. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.
27. Chimowitz MI, DeGeorgia MA, Poole RM, Hepner A, Armstrong WM. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993; 24:1015-9.
28. Kortz RAM, Delemarre BJ, van Dantzig JM, Bot H, Kamp O, Visser CA. Left atrial appendage blood flow determined by transesophageal echocardiography in healthy subjects. Am J Cardiol 1993; 71: 976-81.
29. Oh JK, Seward JB, Tajik AJ. Comprehensive examination according to the referral diagnosis. The Echo Manual 2nd edition. Philadelphia; Lippincott Williams & Wilkins; 1999. p. 251-56.
30. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography: Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639-47.
31. Bilge M, Güler N, Eryonucu B, Erkoc R. Does acute beta blockade reduce left atrial appendage function in patients with chronic non-valvular atrial fibrillation? J Am Soc Echocardiogr 2001; 14: 194-9.
32. Chen PS, Athill CA, WU TJ. Mechanism of atrial fibrillation and flutter and implications for management. Am J Cardiol 1999; 84: 125-30.
33. Akosah KO, Funai JT, Porter TR, Jesse RL, Mohanty PK. Left atrial appendage contractile function in atrial fibrillation: Influence of heart rate and cardioversion to sinus rhythm. Chest 1995; 107: 690-6.